| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute for Neuroscience (B.G.D.), and Section of Integrative Biology and Institute of Behavioral Neuroendocrinology (D.C.), University of Texas at Austin, Austin, Texas 78712
Address all correspondence and requests for reprints to: David Crews, Section of Integrative Biology, 1 University Station C 0930, University of Texas at Austin, Austin, Texas 78712. E-mail: crews{at}mail.utexas.edu.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The all-female desert-grassland whiptail lizard, Cnemidophorus uniparens, reproduces by obligate parthenogenesis and consists of a single clone throughout its range (7). Although males are lacking, individuals engage in pseudosexual behaviors that are identical to the courtship and copulatory behavior of closely related sexual species (8, 9). Individual lizards exhibit a female-like receptive phenotype before ovulation, switching to a male-like pseudocopulatory phenotype after ovulation. These ovarian and behavioral states are correlated with high levels of estrogen (E) before ovulation and high progesterone levels during the postovulatory (PostOv) state. Although androgens are undetectable in circulation throughout the breeding season, C. uniparens is sensitive to exogenous androgen (10). Ovariectomized (OVX) animals will not display pseudosexual behavior, but administration of exogenous testosterone (T) consistently causes individuals to display robust male-like pseudocopulation, whereas exogenous E induces female-like receptivity. This hormonal specificity also extends to the brain with intracranial implantation of T into the preoptic area (POA) inducing mounting behavior, whereas E implantation into the ventromedial nucleus of the hypothalamus (VMN) elicits receptivity (11, 12, 13, 14). Neither T implanted into the VMN nor E into the POA will elicit female- or male-like pseudosexual behaviors, respectively. Therefore, pseudosexual behaviors are both steroid-hormone dependent and brain-nuclei specific.
Neurotransmitters are an important link between sex steroid hormone action and behavior (15, 16). The serotonergic system is responsive to the circulating hormonal milieu, and mediates diverse behaviors in a variety of species, including locomotion in fish (17), and aggression in lizards, crustaceans, and mammals (18, 19, 20, 21). Serotonin (5-HT) inhibits sexual behavior in several vertebrate taxa. For example, the estradiol-induced facilitation of male sexual behavior in the quail is mediated by alterations in serotonergic activity (22). 5-HTs role in rodent sexual behavior has received considerable attention, and, in general, 5-HT is thought to be inhibitory to sexual behavior in both sexes (23, 24). It is noteworthy that an increase in amygdalar serotonergic activity is thought to underlie territorial acquisition, whereas a decrease in raphe serotonergic activity accompanies behavioral sex reversal in the saddleback wrasse (25). Previous research indicates that in C. uniparens, pharmacologically increasing 5-HT levels inhibits male-like pseudosexual behavior in androgen-implanted lizards, whereas decreases in 5-HT levels are correlated with an increased incidence of mounting (26).
In this study we investigate a case for the serotonergic gating of both male- and female-like pseudosexual behavior in naturally cycling and OVX, hormonally manipulated C. uniparens using molecular, pharmacological, and behavioral analyses. Our findings indicate that serotonergic neurotransmission provides a mechanism to regulate the expression of one behavior (e.g. mounting) and the simultaneous suppression of the complementary pattern (e.g. receptivity), and vice versa. These data, and findings in other species, including mammals, suggest that common neural substrates govern male- and female-typical behaviors, and neurochemical signaling between the POA and VMN mediates the complementarity observed during sexual encounters.
| Materials and Methods |
|---|
|
|
|---|
Behavioral testing
In all experiments, animals were tested for male-like pseudocopulation (10-min test) and female-like receptivity (2-min test). The order, whether the experimental animal was tested first with a receptive stimulus animal for male-like mounting or with a mounting stimulus animal, was counterbalanced within each group and experiment. To test for male-like pseudocopulation, a receptive stimulus animal (OVX and estradiol injected) was introduced into the test animals tank, and the time taken by the experimental animal to mount the stimulus animal was recorded (latency to mount). Mounting behavior involves climbing on the back of the stimulus animal and being aligned along the longitudinal axis. The riding animal then assumes a characteristic doughnut posture by wrapping itself around the stimulus animal (pseudocopulation). Female-like receptivity was tested by introducing the experimental animal into the tank of an OVX and T-implanted stimulus animal that had previously shown robust male-like pseudocopulation. The experimental animal was characterized as being receptive (allowed stimulus animal to mount with no resistance) or nonreceptive (showed resistance to being mounted by biting or fleeing from the stimulus animal). All animals were also tested for general motivation and locomotor activity after testing for pseudosexual behavior by recording the number of steps taken in 1 min, movement while chased by the experimenters hand, and the latency to seize a live, moving cricket. Nonreproductive behaviors were not affected in any of the reported experiments, with the effects being specific to pseudosexual behavior (see supplemental Video 1 for pseudosexual behavior, which is which is published as supplemental data on The Endocrine Societys Journals Online web site at http://endo.endojournals.org). After testing for pseudosexual and noncopulatory behavior, animals were killed as noted in specific experiments below (HPLC, ICC, intracranial surgery, and pharmacological experiments).
Naturally cycling animals and hormonal manipulations
PostOv and preovulatory (PreOv) ovarian states were determined by abdominal palpation. Female-like receptivity was then tested by introducing the experimental animal into the tank of an OVX and T-implanted stimulus animal that had previously shown robust male-like pseudocopulation. In addition, ovarian morphology was noted after killing the experimental animal. All PreOv animals were characterized by the presence of developing follicles and a receptive phenotype, whereas PostOv animals had corpora lutea and were nonreceptive.
In the hormonally manipulated conditions, the adult C. uniparens was OVX and implanted with an empty 12-mm SILASTIC brand capsule (Dow Corning, Corp., Midland, MI; 1.47-mm inner diameter, 1.96-mm outer diameter) or with a capsule packed with T (OVX plus T). Independent cohorts of animals were OVX and not implanted but administered ip injections of 0.5 µg estradiol benzoate on 3 d consecutively, 6 d after ovariectomy (OVX plus E). In all instances OVX individuals failed to show either male-like mounting or female-like receptivity in the behavioral tests. In addition, each steroid hormone-treated animal served as its own control in that it was tested for the behavior opposite of that induced by the steroid hormone. The route of hormone administration was dictated by the animals ability to tolerate the hormone. For example, estradiol-filled SILASTIC brand capsules result in the animals death within 1-wk implantation, and, therefore, estradiol needs to be injected rather than implanted (9).
HPLC analysis
Tissue collection for HPLC analysis.
Naturally cycling and hormonally manipulated lizards were decapitated 30 min after behavioral testing, brains rapidly dissected, frozen on dry ice, and stored at –80 C until the time of sectioning. Using a cryostat (Microm HM 500 OM; Microm, Walldorf, Germany), 200-µm coronal sections were thaw mounted onto Superfrost Plus slides (Erie Scientific Co., Portsmouth, NH). Sections were then rapidly frozen using a cooling block set at –20 C (Physitemp Instruments, Inc., Clifton, NJ), and the POA, VMN, and dorsal cortex (CxD) were dissected using a 300-µm diameter micropunch, as per Refs. 28 and 29 . Tissue samples were assayed independently of each other and not pooled. The punched tissue was ejected into ice-cold 70 µl homogenization solution: a mixture of 60 µl homogenization buffer (0.1 M Perchloric acid; Sigma-Aldrich, St. Louis, MO) containing 347 µM sodium bisulfate (Sigma-Aldrich) and 134 µM EDTA disodium salt (Fluka Chemical Corp., Milwaukee, WI), and 10 µl 100 nM Epinine-internal standard (Sigma-Aldrich). Tissue samples in homogenization solution were then stored at –80 C overnight and freeze thawed after 24 h. The thawed samples were centrifuged at 14,000 rpm at 4 C for 20 min, after which the supernate was collected and used for HPLC analysis. Protein content in the resulting pellet was determined by resuspending and agitating the pellet in 45 µl ice-cold 0.3 N NaOH for 24 h at 4 C, and performing a modified Bradford assay thereafter (Pierce, Rockford, IL).
HPLC.
Levels of 5-HT and dopamine (DA) in the POA and VMN were determined by HPLC-electrochemical detection using modifications of Ref. 30 with the assistance of Dr. Herng-Hsiang Lo in the Center for Research on Environmental Disease Analytical Instrumentation Facility Core (University of Texas-Austin). In brief, 50 µl sample was injected into an HPLC system that comprised of a Shimadzu SCL-10A system controller, LC-10AD pump, an SIL-10A auto-sampler (Shimadzu, Columbia, MD), and coupled with a four-channel CoulArray electrochemical detector (ESA, Chelmsford, MA). The isocratic mobile phase contains 4 mM citric acid, 8 mM ammonium acetate, 120 µM 1-octanesulfonic acid sodium salt, 60 µM EDTA disodium in water, and 5% MeOH (pH 3.5). The flow rate of the mobile phase remained at 1 ml/min. Separation was achieved by a 4.6 x 80-mm reverse-phase HR-80, 3 µm particle size column (ESA). The potential of channels 1–4 of CoulArray was set at –50, 0, 300, and 400 mV, respectively. Peak area (nC) of neurochemicals at the corresponding retention time on the chromatogram resulted from 300 mV and was used to quantify the amount based on the standard curve of each neurotransmitter. Recovery of internal standard was consistently high across all experimental runs (95–100%), making it unnecessary to correct for recovery of the internal standard. Neurochemical levels were expressed as pg/µg of protein in the microdissected tissue extract.
Tryptophan hydroxylase (TrpH) immunocytochemistry (ICC)
TrpH ICC was conducted on brain tissue obtained from naturally cycling and hormonally manipulated animals that had been fixed in 4% paraformaldehyde after decapitation. Methods for TrpH ICC and quantification were similar to tyrosine hydroxylase ICC described previously in Ref. 31 , with the exception that sections were incubated for 2 d with a sheep polyclonal antibody that detects TrpH (AB1541, 1:250; CHEMICON International, Inc., Temecula, CA) and cells visualized using a biotinylated goat antisheep secondary antibody (1:200; Vector Laboratories, Burlingame, CA), avidin-biotin-complex, 3'3-diaminobenzidine HCl system. Sections incubated in the absence of a primary antibody served as controls.
Cloning of C. uniparens 5-HT1A and 5-HT2A receptors, and in situ hybridization
Total RNA extracted from the C. uniparens brain using TRIZOL reagent (Invitrogen Corp., Carlsbad, CA) was reverse transcribed using the first-strand cDNA synthesis kit (Invitrogen) and oligo (deoxythymidine) primers. A 77-bp fragment of the 5-HT1A receptor (with 96% identity to rat, mouse, and human 5-HT1A receptor fragments, GenBank accession no. EF628370) and a 155-bp fragment of C. uniparens 5-HT2A receptor (with 95, 93, and 85% identity to rat, mouse, and human 5-HT2A receptor fragments, respectively, GenBank accession no. EF628369) were cloned from this cDNA using a nested primer design and two rounds of PCR. The following primers obtained from Integrated DNA Technologies (Coralville, IA) were used in the PCRs: 5-HT1A, outer primer pair 5'-CTGCAGAACGTGGCCAAYTAYYTNAT-3', 5'-ACAGGATGAAGGTGCCCATDATDAT-3', and inner primer pair 5'-CTGGACCGGTACTGGGCNATHAC-3', 5'-ACAGGATGAAGGTGCCCATDATDAT-3'; and 5-HT2A, outer primer pair 5'-GACATGCTGCTGGGCTTCYTNGTNATGCC-3', 5'-CACCATGATGGTCAGGGGNAYRAARAA-3', and inner primer pair 5'-TGGGCATCTCCATGCCNATHCCNGT-3', 5'-CACCATGATGGTCAGGGGNAYRAARAA-3'.
In situ hybridization was conducted as per Ref. 32 . Briefly, 20-µm fresh frozen coronal sections were sectioned on a cryostat and thaw mounted on Superfrost Plus slides. Slides were then fixed in 4% paraformaldehyde, acetylated, and dehydrated before storage at –80 C. Riboprobes specific to the lizard 5-HT1A and 5-HT2A receptors were transcribed from inserts ligated into the TOPO PCRII vector (Invitrogen) using T7 and SP6 RNA polymerases. All cRNA probes were transcribed using 35S-labeled uridine 5'-triphosphate (PerkinElmer, Inc., Wellesley, MA). Slides were incubated for 16–18 h at 55 C with hybridization buffer [50% formamide, 0.6 M NaCl, 10 mM Tris (pH 7.4), 1x Denhardts solution, 10 mM dithiothreitol, 250 µg/ml yeast transfer RNA, 10% dextran sulfate, and 50 µg/ml herring sperm DNA] and 35S-uridine 5'-triphosphate labeled receptor-specific riboprobes at a concentration of 1 x 106 cpm/150 µl. After hybridization the tissue was washed in 2x saline sodium citrate (SSC) at RT, treated with RNase A (10 µg/ml) at 37 C for 20 min, followed by stringent washes in decreasing concentrations of SSC, with a final wash in 0.25x SSC at RT. Slides were air-dried and exposed to BioMAX-MR (Eastman Kodak Co., Rochester, NY) for 2 wk. Sense riboprobes did not yield significant hybridization (supplemental Fig. 1, B and C), confirming the specificity of the signal observed with the antisense riboprobes. Based on our controls (sense hybridization, RNase pretreatment), as well as our Dig-labeled in situ hybridization, the receptors do indeed seem to be widely expressed much like in other systems studied [in lizards (33), rats (34), and mice (35)]. 5-HT1A and 5-HT2A receptor mRNA levels were analyzed using Scion Image (Scion Corp., Frederick, MD) after performing in situ hybridization. To correct for nonlinearity, 14C standards were used for calibration purposes. The use of C-14 standards when using 35-S labeled probes is routine practice because of a similar emission spectrum of 35-S and C-14 [in primates (36) and rats (37, 38)]. OD measurements using grid sizes of 5 x 5 pixels were obtained from both sides of three to four individual sections from each animal after the specific regions were outlined.
Intracranial injection of 5-HT
Surgeries were performed as per Ref. 39 . Two weeks after implantation, OVX plus T animals were tested for pseudosexual behavior for 3 d consecutively. All animals used in subsequent experimentation mounted a receptive stimulus animal on all 3 d and were nonreceptive. On the day of surgery, animals were tested for pseudosexual and nonreproductive behavior. Animals were then anesthetized using hypothermia (Institutional Animal Care and Use Committee protocol no. 07022602). After verification of the absence of flexor reflex in response to limb extension or toe pinch, the animals were mounted into a modified stereotaxic apparatus (David Kopf Instruments, Tujunga, CA). As part of the modification, a small plastic support stick was taped securely to the bite bar. The anesthetized animals were positioned in the stereotaxic apparatus with their upper jaws above the bite bar and its body resting horizontally on the plastic support stick. The animals were covered with ice to maintain hypothermic conditions. A dental drill with a 1-mm round dental burr was used to drill a hole into the animals skull based on stereotaxic coordinates (see below). A 30-gauge steel cannula attached to polyethylene tubing was inserted to the desired depth, and the compound was injected in a controlled manner using a syringe pump (Razel Scientific, St. Albans, VT). After the injection, the cannula was slowly withdrawn and the skull hole covered using Gelfoam (Pharmacia Corp., Kalamazoo, MI). Animals were then placed back into home tanks immediately and typically recovered within 10 min. Pseudosexual and nonreproductive behavior was tested 20 min after injection. Animals were killed 20 min after behavioral testing, with the brain being fresh frozen on dry ice. Forty micrometer coronal sections were obtained using a cryostat and examined to verify the site of injection.
A separate group of animals was OVX and injected with 0.5 µg estradiol benzoate (OVX plus E) once daily for 3 d consecutively, 2 wk after ovariectomy. These animals that expressed receptive phenotypes were then injected and treated as described previously.
Animals in this experiment received 1 µl unilateral injections of either 0.9% saline or 10 µg 5-HT creatinine sulfate complex over a period of 5 min. Both compounds were mixed with a 0.25% solution of toluidine blue to visualize the site of injection. Using the point of intersection of the two frontal parietal scales and the interparietal scale as the reference point, injections were targeted at the POA (0.1 mm posterior and 0.3 mm ventral to reference point) in the OVX plus T animals, and at the VMN (0.16 mm posterior and 0.38 mm ventral to reference) in the OVX plus E animals. To ensure that the suppression of mounting in OVX plus T animals was related to signaling at serotonergic receptors, we also injected OVX plus T animals with 1.5 mg/kg methysergide maleate ip (a broad 5-HT receptor antagonist) and then injected saline or 5-HT into the POA of these animals 1 h later.
8-Hydroxy-2-(dipropylamino) tetralin (8-OH-DPAT) and 1-(2,5-dimethoxy-4-iodophenyl)-2- aminopropane (DOI) experiments
Three weeks after surgery, OVX plus T animals were tested for pseudosexual behavior on 3 d consecutively. All animals used in the experiment mounted a receptive stimulus animal on all 3 d and were nonreceptive. On the injection day, experimental animals were first tested for pseudosexual behavior (before drug) and nonreproductive behavior. They were then injected ip either with 0.9% saline or 1 mg/kg 8-OH-DPAT. Animals were then tested for pseudosexual behavior and nonreproductive behavior 20 and 45 min after the injection (20 and 45 min after drug, respectively).
A separate group of animals was OVX and allowed to recover for 2 wk. Baseline behavioral testing resulted in no pseudosexual behavior being exhibited by any of these animals. Animals were then subjected to the same injection paradigm as OVX plus T animals. A week after this injection day, OVX animals were injected with 0.5 µg estradiol benzoate (OVX plus E) once daily for 3 d consecutively. One day later, OVX plus E animals showed receptive behavior but did not mount stimulus animals. OVX plus E animals were then injected with either saline or 8-OH-DPAT and tested as described previously. Drug treatments were the same in animals across OVX and OVX plus E states, i.e. animals injected with 8-OH-DPAT in the OVX state were once again injected with 8-OH-DPAT in the OVX plus E state.
A similar experiment was conducted on OVX, OVX plus T, and OVX plus E animals with 1 mg/kg DOI injected ip. In an independent experiment, animals were pretreated with dimethylsulfoxide (vehicle) or 3 mg/kg ketanserin (a 5-HT2A antagonist) ip 20 min before DOI administration to investigate specifically the role of the 5-HT2A receptor in female-typical receptivity.
Statistical analyses
All statistical analyses were conducted using SPSS v12.0 for Windows (SPSS, Inc., Chicago, IL) with significance set at P < 0.05.
HPLC analysis.
Analysis for each region was achieved by conducting multivariate ANOVAs with 5-HT and DA as the dependent variables and hormone or ovarian state as the independent variable. Tukey honestly significant difference (HSD) values were computed for post hoc comparisons and reported.
In situ hybridization.
For each gene, a univariate ANOVA was conducted using hormonal state as the independent variable, and mRNA level as dependent variables.
5-HT administration into the POA.
A univariate ANOVA was conducted using preinjection mount latency as a covariate, treatment (saline or 5-HT) and placement (in or out of the POA) as independent variables, and the postinjection mount latency as the dependent variable. Tukey HSD was used for the purpose of post hoc comparisons.
5-HT administration into the VMN.
Data were analyzed using a binary logistic regression with treatment, placement, and treatment x placement interaction as predictors of receptivity.
8-OH-DPAT administration.
A split plot ANOVA was used to analyze these data using time (0, 20, and 45 min after injection) and treatment (saline or DPAT) as independent variables, with the latency to mount being the dependent variable. Post hoc analysis was accomplished using Tukey HSD.
DOI administration.
Treatment (saline or DOI) and time (0, 20, and 50 min after injection) were used to predict receptivity by conducting a binary logistic regression.
TrpH ICC.
A univariate ANOVA was used to analyze differences in TrpH-immunoreactive cell numbers in the POA and VMN of OVX plus T and OVX plus E lizards with hormonal manipulation and region as the independent variables, and cell number as the dependent variable.
| Results |
|---|
|
|
|---|
|
5-HT receptor subtype mRNA expression in brain nuclei of naturally cycling and hormonally manipulated C. uniparens
PreOv animals have less 5-HT1A mRNA in the POA compared with PostOv lizards (F1,14 = 5.370, P < 0.05) (supplemental Fig. 1, B and C, and Fig. 2
). Similar levels were measured in the CxD and VMN across the ovarian cycle. 5-HT2A mRNA levels in the VMN were significantly lower in the PreOv group compared with PostOv animals (F1,14 = 5.372; P < 0.05) (Fig. 2
). Levels in the POA and CxD were unchanged across both groups.
|
Effect of intracranial injection of 5-HT in the POA and VMN
There was a significant interaction between treatment (saline or 5-HT) and placement (within or outside the POA) on the latency to mount a stimulus receptive animal by OVX plus T-implanted lizards (F1,24 = 9.967; P < 0.01) (Fig. 3B
). Tukey post hoc analysis indicated that animals injected with 5-HT into the POA took significantly longer to mount the stimulus animals compared with all other groups (P < 0.01). No other significant differences between groups were noted. None of the test animals expressed female-like receptivity. Furthermore, ip injection of methysergide (a broad 5-HT receptor antagonist) 1 h before intracranial injection of 5-HT prevented the suppression of male-like pseudocopulation as observed previously (latency to mount: 545 ± 27, mean seconds ± SEM) in four of four OVX plus T animals (latency to mount: 91 ± 31).
|
|
|
|
| Discussion |
|---|
|
|
|---|
Neurotransmitter activity in the POA and VMN is critical to the mediation of sexual behavior in other species. In rats, dopaminergic activity in the POA gates the expression of mounting behavior in males, with low extracellular DA levels in the POA characteristic of noncopulating male rats compared with copulating males (42). 5-HT inhibits sexual behavior in both males and females across a variety of mammalian species (43, 44, 45). Inhibition of 5-HT synthesis by para-chlorophenylalanine increases mounting behavior in both OVX rats, as well as those OVX and implanted with T and E (3, 46, 47, 48). In OVX, E-primed female rats, para-chlorophenylaline increases the lordosis quotient (49). In addition, the destruction of 5-HT neurons by administration of the 5-HT-selective neurotoxin 5,7-DHT into the VMN of OVX and E-implanted female rats induces greater receptivity compared with controls (50). The injection of 5-HT into the POA of male rats suppresses mounting (51), whereas 5-HT injection into the VMN of hormonally primed female rats inhibits lordosis (52). Thus, the literature not only suggests that 5-HT is involved in sex-typical sexual behavior (receptivity) but also in heterotypical sexual behavior (mounting) in the female rat. Related to the idea of gating sexually dimorphic states is the observation that serotonergic neurotransmission at the amygdala, raphe, and POA underlies behavioral sex reversal in the saddleback wrasse (25). Our data are consistent with these findings, and suggest that serotonergic modulation of behavior at the POA and VMN is evolutionarily conserved. The inhibitory effect of 5-HT and signaling via serotonergic receptors on male-like mounting is validated by the short latency of OVX plus T lizards pretreated with methysergide (a broad 5-HT receptor antagonist) and then injected with 5-HT into the POA to mount a stimulus receptive.
Behavioral transitions are usually associated with hormonal transitions, which in turn alter neurotransmitter levels. Hypothalamic 5-HT levels are lower in proestrus female rats than diestrus females as well as intact male rats (53, 54, 55), with this reduction coinciding with the period of maximal receptivity. In contrast, reduced 5-HT levels in the anterior hypothalamus of male compared with female rats in response to prenatal androgen administration are thought to be correlated with the propensity to display male-typical sexual behavior by the males (56). The administration of estradiol and progesterone also alter 5-HT content in hypothalamic nuclei in female rats (57). Correlations between preoptic aromatase activity, fluctuations in monoamine concentrations, and sexual behavior have also been documented in the male Japanese quail (58). OVX lizards do not show either form of pseudosexual behavior, an observation probably related to the high 5-HT levels in both the POA and VMN of OVX lizards. The observed decreases in 5-HT levels in the POA and VMN by hormonal manipulation (OVX plus T and OVX plus E) present one avenue by which hormones alter the threshold for behaviors to be expressed. Our intracranial surgery data and HPLC analysis indicate that fluctuations in 5-HT levels at the POA and VMN as brought about by the circulating hormonal milieu serve to regulate the expression or suppression of male- and female-like pseudosexual behavior, respectively.
One potential explanation for the fluctuation in 5-HT levels across the ovarian and hormonal states might be differences in the number of 5-HT synthesizing neurons in the POA and VMN. TrpH ICC (supplemental Fig. 1A) did not reveal any differences in the number of 5-HT-synthesizing TrpH immunoreactive cell numbers in the POA or VMN of either the naturally cycling (PostOv, n = 8; PreOv, n = 7) or hormonally manipulated animals (OVX plus T, n = 7; OVX plus E, n = 5) (supplemental Fig. 2). Alternatively, the differing 5-HT levels might result from the differential amount of activation of serotonergic neurons in specific brain nuclei, a possibility that warrants further analysis.
5-HT acts via signaling through a diverse family of receptors, including the 5-HT1A and 5-HT2A receptors. Signaling via the 5-HT1A receptor typically facilitates male-typical sexual behavior, whereas 5-HT2A receptor stimulation is associated with an increase in female-typical receptivity (24, 59, 60, 61). Receptor autoradiography reveals both receptor subtypes in the brain of the green anole lizard, Anolis carolinensis (33); 8-OH-DPAT and DOI bind specifically to 5-HT1A and 5-HT2A/2C receptors and have behavioral effects in a reptile (62). It is important to note that the 5-HT1A receptor-mediated facilitation of male sexual behavior in rats and primates occurs at the level of intromission and ejaculation, whereas the number of mounts is actually decreased (63). The absence of hemipenes in C. uniparens obviates any effect on intromission and ejaculation, and the effect of 8-OH-DPAT on increasing mount latency is consistent with the rat and primate literature. Similarly, the facilitation of receptivity through signaling via the 5-HT2A receptor is in agreement with the mammalian literature, and corroborated by the inhibition of DOI-induced receptivity in C. uniparens by pretreatment with the 5-HT2A receptor antagonist ketanserin.
Another mechanism by which hormones affect neurotransmitter dynamics is by altering mRNA and protein levels of specific receptor subtypes. Differences in 5-HT receptor subtype levels and their activity in OVX, hormonally manipulated female rats are thought to underlie the expression of receptivity or the lack thereof (64). We find that steroid hormones alter serotonergic receptor subtype mRNA levels in the POA and VMN of C. uniparens, and this might be responsible for the form of behavior expressed. These observations are similar to the hypothesis that dopaminergic signaling via D1 or D2 receptors mediates distinct aspects of male rat sexual behavior (65), as well as 5-HT1A and 5-HT2A receptor activities, respectively, mediating an inhibitory and facilitatory role of 5-HT on receptivity in female rats (66).
Having determined the involvement of 5-HT in facilitating and suppressing the complementary behaviors in C. uniparens, we are now in a position to investigate further the interaction between the ovarian hormonal milieu and 5-HT. For example, are steroid receptors present in 5-HT synthesizing neurons as observed in nonhuman primates and rodents (67, 68, 69), and could they affect processes within these neurons to mediate behavior? Given that interactions between nitric oxide and 5-HT are known to contribute to aggression in mice (70), and 5-HT and DA interact to affect sexual behavior in male rats (71), it would be interesting to examine the same interaction in the whiptail lizard, in light of the demonstrated roles of nitric oxide and DA in mediating sexual behavior in Cnemidophorus lizards (72, 73).
The gating of sex-typical behavior has been attributed to both peripheral and central mechanisms. For example, Trpc2 channels in the vomeronasal organ appear to be involved in the suppression of mounting behavior in female mice (74), and in rats light acting via the suprachiasmatic nucleus (the neural generator of circadian rhythms) may be responsible for the appropriate display of sex-typical behaviors (75, 76). However, usually when mention is made of the complementarity of sexual behavior, the gating of behavioral expression is attributed to independently acting mechanisms at the POA (mounting) and VMN (receptivity). Our study suggests that serotonergic neurotransmission allows for male-typical mounting and female-typical receptivity to be gated by the appropriate hormonal state, and social context within and between interacting individuals. Social behaviors exhibited by males and females share common neural networks (77), and our data suggest that it is the neurochemistry at the POA and VMN, in concert with the stimulus partners qualities, that dictates behavioral output.
The present study not only sheds light on the mechanisms underlying male-typical mounting and female-typical receptivity but also extends our understanding of how brain mechanisms controlling sexually dimorphic behavioral traits may have evolved. By focusing on the neural substrates underlying sex-typical behaviors in a parthenogen, we avoid the confounding factors of genotype and endocrine history inherent in studies with gonochoristic species with genotypic sex determination (9). Sexual behavior in genetic male Cnemidophorus inornatus (the sexual ancestor) is dependent upon testicular androgens, although a polymorphism exists in sensitivity to progesterone, with exogenous progesterone inducing the full suite of sexual behavior in about a third of castrated male C. inornatus. This is presumed to be the basis of the novel neuroendocrine mechanism controlling male-like pseudosexual behavior in the descendant C. uniparens, which is normally initiated by the PostOv progesterone. Although no detectable levels of androgen have ever been measured in the circulatory system of unisexual lizards, they have androgen receptor in the same brain areas as the ancestral species and are extremely sensitive to androgen, showing a robust mounting response when implanted with T. By taking advantage of the conserved nature of male-typical mounting as triggered robustly by T, we are able to focus on how the neurochemistry at specific brain nuclei interact in a circuit to elicit normally sex-typical behaviors independent of the nature of the hormonal trigger. The similarities in neurochemical level and receptor mRNA profiles in PostOv animals and OVX plus T lizards allow us to postulate overarching commonalities in the mechanisms gating the expression of mounting behavior.
The findings reported in this study also speak to how sexually differentiated traits might occur. The canonical concept that the female sex is the default or neutral sex, and males are the organized sex has proved overly simplistic (2). Research on sex determination in humans, transgenic mice, and species lacking sex chromosomes reveals that both sexes are organized, the difference lying in the patterns of expression of gonad-differentiating genes (5, 78, 79, 80). That is, the differentiation of the primordial gonads into a testicular or an ovarian phenotype depends upon a common conserved gene network, with sex specificity lying in the trigger (genotypic such as Sry in mammals or environmental such as temperature in turtles) that modulates the patterns of expression of genes of this gonad-differentiating network.
Given that the first "sex" was female, and E receptor is the most ancestral sex steroid hormone receptor (81, 82), it is more appropriate to consider the female and E as ancestral, and the male and androgen as derived, states. Although the concept of ovarian development as the ancestral pathway, with certain triggers sculpting testicular development, has been the subject of extensive investigation, this idea has seldom been discussed within the framework of sexual behavior. This alternate concept of the female as the ancestral, and the male as the derived, sex (5) maintains the element of the "male phenotype" being imposed on what otherwise would be a "female phenotype" but extends research in new theoretical directions. If in fact males are the derived sex, it follows that males may be more like females than females are like males (83). Previously, several lines of evidence were offered to support this idea, such as the relative ease of masculinizing animals compared with the difficulty of defeminizing animals and the resurrection of males in parthenogenetic whiptails (84, 85), indicating that the genes of male traits are present in this all-female species. It is widely accepted that in gonochoristic species, both males and females possess the neuronal circuitry and molecular pathways to mediate both mounting and receptivity, with one behavioral trajectory being suppressed as a consequence of sexual differentiation. A novel perspective from the present data lies in the implication that being receptive might be the ancestral reproductive behavior of vertebrates, and the evolution of males and their attendant male-typical behavior required the masking of this receptive phenotype. To our knowledge, this is the first demonstration that a single molecule regulates the simultaneous complementarity of sex-typical behaviors within the same sex, and sheds light on the mechanisms and potential evolution by which homotypical and heterotypical sex behaviors might be balanced within a sex.
| Acknowledgments |
|---|
| Footnotes |
|---|
Disclosure Statement: The authors have nothing to disclose.
First Published Online May 15, 2008
Abbreviations: CxD, Dorsal cortex; DA, dopamine; DOI, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane; E, estrogen; HSD, honestly significant difference; 8-OH-DPAT, 8-hydroxy-2-(dipropylamino) tetralin; ICC, immunocytochemistry; OVX, ovariectomized; POA, preoptic area; PostOv, postovulatory; PreOv, preovulatory; 5-HT, serotonin; SSC, standard saline solution; T, testosterone; TrpH, tryptophan hydroxylase; VMN, ventromedial nucleus of the hypothalamus.
Received February 13, 2008.
Accepted for publication May 7, 2008.
| References |
|---|
|
|
|---|
-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity. Chem Res Toxicol 12:1150–1157[CrossRef][Medline]
2 adrenoceptor subtype mRNAs in adult and developing rat brain. Brain Res Brain Res Protoc 3:229–241[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |